Neuralink commenced its first human clinical trial in January 2024 by implanting a BCI device in a patient named Noland ...
In an interview, Antoni Vilaseca Cabo, MD, discussed the clinical activity of TAR-210 in patients with non-muscle invasive ...
"Dosing the first patient with Bria-OTS™ is a significant milestone for both BriaCell and cancer patients,” stated Giuseppe ...
On September 12 th, Bright Minds Biosciences announced the initiation of the BREAKTHROUGH Study, an open-label Phase 2 ...
Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease ...
Objective Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a loss of immune tolerance, affecting ...
MD students at NYU Grossman School of Medicine complete scholarly research projects as part of a concentration in an area of interest.
A group of investigators led by Cedars-Sinai have developed and successfully tested a new artificial intelligence (AI) method ...
Cancer Cytogenomic Laboratory, Center for Research and Drug Development ... and the role of machine learning in clinical decision making, suggests that more robust updates are necessary to fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback